rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Douglas P. Golwas

Chief Commercial Officer

Company insider

Files Form 4 as: Chief Commercial Officer, Medline.

Every Form 4 they filed

In numbers

Trades disclosed
28
Buys
0
Sells
1
Bought
$0
Sold
$7.4M
Companies
1
Companies where not an officer
0
First trade
16 Dec 2025
Last trade
16 Jun 2026
Last filed
17 Jun 2026

Companies traded

Where they are an officer
MDLN MedlineOfficer, 10% owner · Medical Devices · last 16 Jun 20260 buys · 1 sell

Activity over time

1 Jun – 1 Oct
10Jun 26Jul 26Aug 26Sep 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
16 Jun 2026filed 17 Jun 2026MDLN MedlineMedical DevicesSEC FORM 4 Code M—100,000filing
16 Jun 2026filed 17 Jun 2026MDLN MedlineMedical DevicesSEC FORM 4 Sold$2.3M61,966 at $36.60filing
16 Jun 2026filed 17 Jun 2026MDLN Medlineoption or derivative · Medical DevicesSEC FORM 4 Code M—100,000 at $0.00filing
16 Jun 2026filed 17 Jun 2026MDLN MedlineMedical DevicesSEC FORM 4 Sold$1.4M38,034 at $37.05filing
16 Jun 2026filed 17 Jun 2026MDLN MedlineMedical DevicesSEC FORM 4 Code D—100,000filing
16 Jun 2026filed 17 Jun 2026MDLN Medlineoption or derivative · Medical DevicesSEC FORM 4 Code M—100,000 at $0.00filing
16 Jun 2026filed 17 Jun 2026MDLN MedlineMedical DevicesSEC FORM 4 Code M—100,000filing
16 Jun 2026filed 17 Jun 2026MDLN MedlineMedical DevicesSEC FORM 4 Sold$2.3M61,966 at $36.60filing
16 Jun 2026filed 17 Jun 2026MDLN MedlineMedical DevicesSEC FORM 4 Sold$1.4M38,034 at $37.05filing
16 Jun 2026filed 17 Jun 2026MDLN MedlineMedical DevicesSEC FORM 4 Code D—100,000filing
15 Jun 2026filed 17 Jun 2026MDLN MedlineMedical DevicesSEC FORM 4 Code F$69K1,889 at $36.61filing
15 Jun 2026filed 17 Jun 2026MDLN MedlineMedical DevicesSEC FORM 4 Code F$69K1,889 at $36.61filing
5 Mar 2026filed 6 Mar 2026MDLN MedlineMedical DevicesSEC FORM 4 Code A—25,788 at $0.00filing
5 Mar 2026filed 6 Mar 2026MDLN MedlineMedical DevicesSEC FORM 4 Code A—25,788 at $0.00filing
16 Dec 2025filed 6 Mar 2026MDLN MedlineMedical DevicesSEC FORM 4 Code A—465,864filing
16 Dec 2025filed 6 Mar 2026MDLN Medlineoption or derivative · Medical DevicesSEC FORM 4 Code A—465,864filing
16 Dec 2025filed 6 Mar 2026MDLN Medlineoption or derivative · Medical DevicesSEC FORM 4 Code A—465,864filing
16 Dec 2025filed 6 Mar 2026MDLN Medlineoption or derivative · Medical DevicesSEC FORM 4 Code A—948,597filing
16 Dec 2025filed 6 Mar 2026MDLN Medlineoption or derivative · Medical DevicesSEC FORM 4 Code A—463,211filing
16 Dec 2025filed 6 Mar 2026MDLN Medlineoption or derivative · Medical DevicesSEC FORM 4 Code A—212,755filing

News

NovoCure (NASDAQ:NVCR) and Medline (NASDAQ:MDLN) Financial AnalysisMDLN · themarketsdaily.com · 8 Oct 2026

0 headlines in the last 90 days name Douglas P. Golwas; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.

Sectors

Health Care1

Buys in green, sells in red, by the company’s sector.

Related people

GIC Private Ltd10% owner · 10% owner at Medline, filing Form 4 there in the last year
Stephen L. MillerChief Operating Officer · Chief Operating Officer at Medline, filing Form 4 there in the last year
James M. BoyleChief Executive Officer · Chief Executive Officer at Medline, filing Form 4 there in the last year
Mozart Holdco, Inc.10% owner · 10% owner at Medline, filing Form 4 there in the last year
Amanda H. LaabsChief Product Officer · Chief Product Officer at Medline, filing Form 4 there in the last year